<DOC>
	<DOCNO>NCT01871077</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability ophthalmic solution PRO-156 ocular surface ophthalmologically healthy volunteer</brief_summary>
	<brief_title>Safety Tolerability Ophthalmic Solution PRO-156 Ophthalmologically Healthy Volunteers .</brief_title>
	<detailed_description>A phase I , open label unicentric clinical trial evaluate safety tolerability ophthalmic solution PRO-143 ocular surface ophthalmologically healthy volunteer .</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Healthy male female . Age 18 40 year old screening visit . Signed informed consent Patient one blind eye . Any ocular systemic condition . Visual acuity 20/100 eye . Use ocular systemics medication . Contraindications sensitivity component study treatment . Contact lens user . Ocular surgery within past 3 months.. Pregnant , nurse childbearing potential woman use effective contraception . Participation study investigational drug within 90 day previous inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>